PPT-A Randomized Adaptive Platform Trial
Author : bitsy | Published Date : 2024-01-03
Comparing Multiple Treatments for Ebola Virus Disease A Discussion of Ethical Ramifications Scott Berry 28 Nov 2017 1 2 Classical Trial Disease Control 3 Treatment
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "A Randomized Adaptive Platform Trial" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
A Randomized Adaptive Platform Trial: Transcript
Comparing Multiple Treatments for Ebola Virus Disease A Discussion of Ethical Ramifications Scott Berry 28 Nov 2017 1 2 Classical Trial Disease Control 3 Treatment Platform Trial perpetual. Randomiza tion if done properly can keep study groups as similar as possible at the outset so that the investigators can isolate and quantify the effect of the interventions they are studying No other study design gives us the power to balance unkno Adaptivity. in Sparse Recovery. Piotr. . Indyk. MIT. Joint work . with Eric . Price and David Woodruff, 2011.. Sparse recovery. (approximation theory, statistical model selection, information-based complexity, learning Fourier . Michael Ben-Or. The Hebrew University. Michael Rabin’s Birthday Celebration. Randomized Protocols. Power of Randomization. Exponential . speedup for known algorithms. Complexity . – The jury is still out . Global Forum on Bioethics in Research. :. Emerging Epidemic Infections and Experimental Treatments. November 4, 2015. Lord Kelvin. I often say that when you can measure what you are speaking about and express it in numbers, you know something about it; but when you cannot measure it, when you cannot express it in numbers, your knowledge is of a meagre and unsatisfactory kind; it may be the beginning of knowledge, but you have scarcely in your thoughts advanced to the state of Science, whatever the matter may be.. Adaptivity. in Sparse Recovery. Piotr. . Indyk. MIT. Joint work . with Eric . Price and David Woodruff, 2011.. Sparse recovery. (approximation theory, statistical model selection, information-based complexity, learning Fourier . Holger Thiele, . MD. o. n behalf of the CULPRIT-SHOCK Investigators. Disclosure Statement of Financial Interest. Grant/Research . Support. Consulting Fees/Honoraria. Major Stock Shareholder/Equity. Royalty Income. Developer’s Guide to Windows 10. Andy Wigley Shen Chauhan. Easy for users to get & stay current. Unified core . and app platform. The convergence journey. Windows Phone 7.5. Windows Phone 8. Mahesh Parmar. MRC . Clinical Trials Unit at . UCL. Rationale . for adaptive trials. Our . adaptive trials and their setting. Discuss some broad practical and statistical challenges. Offer some solutions and thoughts. Alternative Study Designs and Randomization Schemes. Demonstrated on . Paul Murphy. nQuery Research Statistician. Webinar host. Host. AGENDA. 1) . Background. 2) Crossover Trials. 3) Cluster Randomized Trials. Protocol Chairs: . Darrell Baskin & Mathew MacCumber. Background. Although vitrectomy with ERM peeling has a high success rate, some patients experience less than optimal VA improvement. Patients with significant macular changes on OCT but relatively good vision are often advised to defer surgery until vision declines to 20/40 or worse. Outline. Review of a phase I trial. What is a phase II trial?. Phase II trial process. Standard trial designs. Innovative trial designs. Phase II trial examples. Guess that trial. Phase II thalidomide study. Features of adaptive immunity:. Adaptive immunity is characterized by the following:. 1. Antigenic specificity: (. highly specific).. 2. Diversity : . ( each antigen there is specific T-cell and B-cell for it).. Patrick Phillips, PhD. Associate Professor. Department of Medicine. Department of Epidemiology and Biostatistics. Patrick.Phillips@ucsf.edu. Outline. Decision-making in Medicine. The Randomized Trial. M. Nyer. 1, 2. , M. Nagaswami. 1. , S. Tuchman. 1. , L. Hopkins. 3. , F. Jain. 1, 2. , C. Streeter. 2, 4. , M. Fava. 1, 2. , D. Mischoulon. 1, 2. 1. . Depression Clinical and Research Program (DCRP), Department of Psychiatry, Massachusetts General...
Download Document
Here is the link to download the presentation.
"A Randomized Adaptive Platform Trial"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents